The Vernacular of Risk--Rethinking Direct-to-Consumer Advertising of Pharmaceuticals.
From the Division of General Internal Medicine and the Department of the History of Medicine, Johns Hopkins University School of Medicine, Baltimore (J.A.G.); and the Department of Anthropology, History and Social Medicine, University of California, San Francisco, School of Medicine, San Francisco (E.S.W.).
Jeremy A
JA
Greene
Elizabeth S
ES
Watkins
D000329:Advertising / Q000331:legislation & jurisprudence*; D003276:Contraceptives, Oral / Q000009:adverse effects / Q000266:history; D004345:Drug Industry / Q000266:history / Q000331:legislation & jurisprudence; D004348:Drug Labeling / Q000266:history* / Q000331:legislation & jurisprudence; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D033161:Government Regulation / Q000266:history*; D049673:History, 20th Century; D006801:Humans; D007880:Legislation, Drug / Q000266:history*; D055553:Prescription Drugs / Q000009:adverse effects / Q000266:history*; D011639:Public Opinion; D014481:United States; D014486:United States Food and Drug Administration / Q000266:history*
D003276:Contraceptives, Oral; D055553:Prescription Drugs